RO7049389 is safe, well tolerated in chronic hepatitis B treatment

RO7049389 is safe, well tolerated in chronic hepatitis B treatment

Core protein allosteric modulator RO7049389 was safe and demonstrated antiviral activity in patients with chronic hepatitis B infection, according to research published in Lancet Gastroenterology and Hepatology.“Current treatment options for patients with chronic HBV infection comprise two classes of drugs: subcutaneously administered interferon preparations and orally administered nucleotide analogues. Neither treatment achieves a high rate of functional cure, defined as sustained loss of hepatitis B surface antigen with or without seroconversion to [hepatitis B surface] antibodyRead More

Share on facebook
Share on twitter
Share on linkedin